National Research Co. (NASDAQ:NRC) Shares Bought by Millennium Management LLC

Millennium Management LLC grew its stake in National Research Co. (NASDAQ:NRCFree Report) by 200.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 214,858 shares of the company’s stock after acquiring an additional 143,454 shares during the quarter. Millennium Management LLC owned about 0.90% of National Research worth $4,931,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in NRC. CWM LLC grew its stake in National Research by 889.7% during the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after purchasing an additional 1,041 shares in the last quarter. Benjamin F. Edwards & Company Inc. grew its holdings in National Research by 860.2% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock worth $45,000 after acquiring an additional 1,015 shares during the period. Principal Financial Group Inc. acquired a new stake in National Research in the 1st quarter valued at about $221,000. Precision Wealth Strategies LLC lifted its holdings in National Research by 7.9% in the 1st quarter. Precision Wealth Strategies LLC now owns 5,623 shares of the company’s stock valued at $223,000 after acquiring an additional 413 shares during the last quarter. Finally, BOKF NA purchased a new stake in National Research during the first quarter valued at about $243,000. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Price Performance

NRC stock opened at $18.86 on Friday. The firm has a market capitalization of $450.19 million, a PE ratio of 15.59 and a beta of 0.49. National Research Co. has a one year low of $18.70 and a one year high of $44.60. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.64. The firm has a 50-day moving average of $21.45 and a two-hundred day moving average of $26.48.

National Research (NASDAQ:NRCGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The firm had revenue of $35.02 million for the quarter.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were given a $0.12 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.55%. National Research’s dividend payout ratio is 39.67%.

National Research Company Profile

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Further Reading

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRCFree Report).

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.